Advertisement
Canada markets closed

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7302
    +0.0004 (+0.06%)
     

  • CRUDE OIL

    82.83
    +0.02 (+0.02%)
     

  • Bitcoin CAD

    88,130.69
    -3,134.15 (-3.43%)
     

  • CMC Crypto 200

    1,389.34
    -34.76 (-2.44%)
     

  • GOLD FUTURES

    2,322.00
    -16.40 (-0.70%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,462.00
    -202.50 (-1.15%)
     

  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • NIKKEI 225

    37,818.11
    -641.97 (-1.67%)
     

  • CAD/EUR

    0.6818
    -0.0001 (-0.01%)
     

CC FINAL DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages The Chemours Company (CC) Investors Who Suffered Significant Losses to Contact Its Attorneys: Application Deadline Tomorrow

ACCESSWIRE

SAN FRANCISCO, CA / ACCESSWIRE / December 8, 2019 / Hagens Berman urges The Chemours Company (CC) investors who have suffered significant losses on Chemours common stock, options and/or bonds to submit their loss now to learn if they qualify to recover their investment losses. Only one day remains until the December 9, 2019 lead plaintiff deadline in a securities fraud class action pending against the company.

Class Period: Feb. 16, 2017 - Aug. 1, 2019
Lead Plaintiff Deadline: Dec. 9, 2019
Sign Up: www.hbsslaw.com/investor-fraud/CC
Contact An Attorney Now: CC@hbsslaw.com
844-916-0895

The New Chemours Company (CC) Securities Class Action:

A recent class action was filed against the company and its senior executives, which now includes all purchasers of Chemours' publicly traded securities, including common stock, options and bonds.

ADVERTISEMENT

The eligible security IDs are as follows: 163851108, 163851AA6, 163851AB4, 163851AD0, 163851AE8, AS7476128, EK8986813, US1638511089, US163851AA61, US163851AB45, US163851AD01, US163851AE83, USU16309AA13, XS1827600724, BDB7NR8, BDB7NS9, BDFVFH0, BDGH0J4, BWG09Q6, BXC7XM2, and BZ0CTP8.

According to the Complaint, Defendants misled investors by inappropriately accounting and accruing reserves for its environmental liabilities.

Beginning on May 6, 2019, investors began to learn the truth about Chemours' improper accounting through a series of partial disclosures ending on August 1, 2019.

"We're focused on investors' losses and whether Chemours concealed its environmental liability from investors," said Hagens Berman partner Reed Kathrein.

Whistleblowers: Persons with non-public information regarding Chemours should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email CC@hbsslaw.com.

# # #

About Hagens Berman
Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact:

Reed Kathrein, 844-916-0895

SOURCE: Hagens Berman Sobol Shapiro LLP



View source version on accesswire.com:
https://www.accesswire.com/569458/CC-FINAL-DEADLINE-ALERT-HAGENS-BERMAN-NATIONAL-TRIAL-ATTORNEYS-Encourages-The-Chemours-Company-CC-Investors-Who-Suffered-Significant-Losses-to-Contact-Its-Attorneys-Application-Deadline-Tomorrow